NCT07827235

Brief Summary

This cross-sectional study aims to determine the frequency and spectrum of thyroid disorders among children with autoimmune hepatitis attending Assiut University Children's Hospital.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for all trials

Timeline
16mo left

Started Sep 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress4%
Sep 2026Feb 2028

First Submitted

Initial submission to the registry

September 14, 2026

Completed
1 day until next milestone

Study Start

First participant enrolled

September 15, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 18, 2026

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 25, 2027

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 10, 2028

Last Updated

September 22, 2026

Status Verified

September 1, 2026

Enrollment Period

1 year

First QC Date

September 14, 2026

Last Update Submit

September 18, 2026

Conditions

Keywords

Autoimmune hepatitisThyroid disordersAnti-TPOPediatricAssiut

Outcome Measures

Primary Outcomes (1)

  • Frequency of thyroid disorders

    Number of participants with autoimmune hepatitis who have any thyroid disorder including overt or subclinical hypothyroidism, hyperthyroidism, or autoimmune thyroiditis based on thyroid function tests, autoantibodies, and ultrasonography

    Baseline

Secondary Outcomes (6)

  • Pattern of thyroid disorders

    Baseline

  • Thyroid autoantibody positivity

    Baseline

  • Thyroid ultrasonographic abnormalities

    Baseline

  • Serum TSH level

    Baseline

  • Serum free T4 level

    Baseline

  • +1 more secondary outcomes

Study Arms (1)

Single cohort: Children with autoimmune hepatitis

Children less than 18 years with autoimmune hepatitis who will undergo thyroid function tests, thyroid autoantibodies, and thyroid ultrasonography.

Eligibility Criteria

AgeUp to 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Children less than 18 years diagnosed with autoimmune hepatitis attending the Pediatric Hepatology Unit and Outpatient Clinic at Assiut University Children's Hospital.

You may qualify if:

  • Age less than 18 years
  • Diagnosis of autoimmune hepatitis according to the Revised International Autoimmune Hepatitis Group (IAIHG) scoring system
  • Written informed consent from parents or legal guardians

You may not qualify if:

  • \- Previously diagnosed thyroid disorders before the diagnosis of autoimmune hepatitis
  • Medications known to interfere with thyroid function tests (other than corticosteroids or immunosuppressive therapy for AIH)
  • Chronic systemic diseases known to affect thyroid function independently of AIH
  • Other autoimmune disorders (celiac disease, diabetes, inflammatory bowel disease)
  • Refusal to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Mieli-Vergani G, Vergani D, Baumann U, Czubkowski P, Debray D, Dezsofi A, Fischler B, Gupte G, Hierro L, Indolfi G, Jahnel J, Smets F, Verkade HJ, Hadzic N. Diagnosis and Management of Pediatric Autoimmune Liver Disease: ESPGHAN Hepatology Committee Position Statement. J Pediatr Gastroenterol Nutr. 2018 Feb;66(2):345-360. doi: 10.1097/MPG.0000000000001801.

    PMID: 29356770BACKGROUND
  • Ijaz MK, Sattar SA, Boone SA, Nims RW, McKinney J, Gerba CP. Dynamics of respiratory virus spread indoors suggest a holistic approach for exposure risk mitigation. Antimicrob Steward Healthc Epidemiol. 2025 Oct 29;5(1):e289. doi: 10.1017/ash.2025.10147. eCollection 2025.

    PMID: 41180295BACKGROUND
  • Chen M, Gu H, Xuan G, Ma L, Tu S, Li M. Elective neck dissection versus elective neck irradiation in cT3/4N0 maxillary sinus squamous cell carcinoma: a propensity score matching analysis. World J Surg Oncol. 2024 Apr 15;22(1):95. doi: 10.1186/s12957-024-03368-8.

    PMID: 38622695BACKGROUND

MeSH Terms

Conditions

Thyroid DiseasesHepatitis, AutoimmuneHashimoto DiseaseGraves Disease

Condition Hierarchy (Ancestors)

Endocrine System DiseasesHepatitis, ChronicHepatitisLiver DiseasesDigestive System DiseasesAutoimmune DiseasesImmune System DiseasesThyroiditis, AutoimmuneThyroiditisExophthalmosOrbital DiseasesEye DiseasesGoiterHyperthyroidism

Study Officials

  • Amal A seliman, prof

    pediatrics Department, Assiut University Hospitals

    STUDY CHAIR
  • Shereen M Galal, Prof

    pediatrics Department, Assiut University Hospitals

    STUDY CHAIR

Central Study Contacts

Arwa M Mohamed, Resident

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident Physician, Pediatrics

Study Record Dates

First Submitted

September 14, 2026

First Posted

September 18, 2026

Study Start

September 15, 2026

Primary Completion (Estimated)

September 25, 2027

Study Completion (Estimated)

February 10, 2028

Last Updated

September 22, 2026

Record last verified: 2026-09